Mustapha Faroudi

Title: Mustapha Faroudi: Innovator in Immuno-Oncology

Introduction

Mustapha Faroudi is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of immuno-oncology, particularly through his innovative patents. With a total of 3 patents, Faroudi's work focuses on developing novel therapeutic approaches for cancer treatment.

Latest Patents

Faroudi's latest patents include a bispecific antibody designed for ICOS and PD-L1. This multispecific antibody is structured in an mAb2 format, incorporating an ICOS-binding Fab region and a PD-L1-binding Fcab region. The application of this antibody is particularly relevant in immuno-oncology, especially for the treatment of solid tumors. Additionally, he has developed combination therapies that include antibodies targeting other immune checkpoint molecules such as PD-1 and CTLA-4, alongside anti-ICOS and anti-PD-L1. Another notable patent involves FC binding fragments that comprise a PD-L1 antigen-binding site. These specific binding members are designed to bind to programmed death-ligand (PD-L1) and have potential applications in treating cancer, infectious diseases, and inflammatory conditions.

Career Highlights

Throughout his career, Mustapha Faroudi has worked with notable companies in the biotechnology sector, including F-star Therapeutics, Inc. and Kymab Limited. His expertise in antibody development and immunotherapy has positioned him as a key figure in advancing cancer treatment methodologies.

Collaborations

Faroudi has collaborated with several professionals in his field, including Mihriban Tuna and Francisca Wollerton Van Horck. These collaborations have further enriched his research and development efforts in immuno-oncology.

Conclusion

Mustapha Faroudi's innovative work in the field of immuno-oncology demonstrates his commitment to advancing cancer therapies through his patented inventions. His contributions are paving the way for new treatment options that could significantly impact patient outcomes.